We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Marc Garnick

Marc B Garnick MD

Director of Cancer Community Services, Network Development, BIDMC; the Gorman Brothers Professor of Medicine at Harvard Medical School (HMS)

Dr. Garnick is a physician in the Division of Hematology/Oncologyof the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC); serves as Director of Cancer Community Services, Network Development, BIDMC; is the Gorman Brothers Professor of Medicine at Harvard Medical School(HMS) and serves as a special advisor to the Oncologic Drugs Advisory Committee of the FDA.

Dr. Garnick is a world-renowned clinician and clinical investigator in prostate cancer and other urologic cancers.  At BIDMC, he founded the Hershey Family Program for Prostate Cancer Research.  Dr. Garnick is also involved in the development of oncologic products through biotechnology. He has made it his personal mission to help patients navigate the maze of treatment options to help them make informed decisions. Dr. Garnick is editor-in-chief of The Annual Report on Prostate Diseases, Harvard Medical School’s award-winning publication and authored “The Patient’s Guide to Prostate Cancer.”